Association of the CYP3A5 A6986G (CYP3A5*3) polymorphism with saquinavir pharmacokinetics

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Fröhlich, Margit (VerfasserIn) , Hoffmann, Michael Marcus (VerfasserIn) , Burhenne, Jürgen (VerfasserIn) , Mikus, Gerd (VerfasserIn) , Weiß, Johanna (VerfasserIn) , Haefeli, Walter E. (VerfasserIn)
Dokumenttyp: Article (Journal) Editorial
Sprache:Englisch
Veröffentlicht: 21 June 2004
In: British journal of clinical pharmacology
Year: 2004, Jahrgang: 58, Heft: 4, Pages: 443-444
ISSN:1365-2125
DOI:10.1111/j.1365-2125.2004.02159.x
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1111/j.1365-2125.2004.02159.x
Verlag, lizenzpflichtig, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884607/
Volltext
Verfasserangaben:Margit Fröhlich, Michael M Hoffmann, Jürgen Burhenne, Gerd Mikus, Johanna Weiss & Walter E Haefeli

MARC

LEADER 00000caa a2200000 c 4500
001 1758140259
003 DE-627
005 20230427100720.0
007 cr uuu---uuuuu
008 210519s2004 xx |||||o 00| ||eng c
024 7 |a 10.1111/j.1365-2125.2004.02159.x  |2 doi 
035 |a (DE-627)1758140259 
035 |a (DE-599)KXP1758140259 
035 |a (OCoLC)1341413545 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Fröhlich, Margit  |e VerfasserIn  |0 (DE-588)1233708236  |0 (DE-627)1758071524  |4 aut 
245 1 0 |a Association of the CYP3A5 A6986G (CYP3A5*3) polymorphism with saquinavir pharmacokinetics  |c Margit Fröhlich, Michael M Hoffmann, Jürgen Burhenne, Gerd Mikus, Johanna Weiss & Walter E Haefeli 
264 1 |c 21 June 2004 
300 |a 2 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 19.05.2021 
700 1 |a Hoffmann, Michael Marcus  |e VerfasserIn  |0 (DE-588)114719683  |0 (DE-627)691227306  |0 (DE-576)287521168  |4 aut 
700 1 |a Burhenne, Jürgen  |d 1963-  |e VerfasserIn  |0 (DE-588)1034228889  |0 (DE-627)745126987  |0 (DE-576)381858197  |4 aut 
700 1 |a Mikus, Gerd  |e VerfasserIn  |0 (DE-588)110903137  |0 (DE-627)691097941  |0 (DE-576)336988710  |4 aut 
700 1 |a Weiß, Johanna  |e VerfasserIn  |0 (DE-588)1050230906  |0 (DE-627)783666322  |0 (DE-576)404441114  |4 aut 
700 1 |a Haefeli, Walter E.  |d 1958-  |e VerfasserIn  |0 (DE-588)124572359  |0 (DE-627)656806141  |0 (DE-576)340514221  |4 aut 
773 0 8 |i Enthalten in  |t British journal of clinical pharmacology  |d Oxford : Wiley-Blackwell, 1974  |g 58(2004), 4, Seite 443-444  |h Online-Ressource  |w (DE-627)306585995  |w (DE-600)1498142-7  |w (DE-576)091140056  |x 1365-2125  |7 nnas  |a Association of the CYP3A5 A6986G (CYP3A5*3) polymorphism with saquinavir pharmacokinetics 
773 1 8 |g volume:58  |g year:2004  |g number:4  |g pages:443-444  |g extent:2  |a Association of the CYP3A5 A6986G (CYP3A5*3) polymorphism with saquinavir pharmacokinetics 
856 4 0 |u https://doi.org/10.1111/j.1365-2125.2004.02159.x  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884607/  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210519 
993 |a Editorial 
994 |a 2004 
998 |g 124572359  |a Haefeli, Walter E.  |m 124572359:Haefeli, Walter E.  |d 910000  |d 910100  |e 910000PH124572359  |e 910100PH124572359  |k 0/910000/  |k 1/910000/910100/  |p 6  |y j 
998 |g 1050230906  |a Weiß, Johanna  |m 1050230906:Weiß, Johanna  |d 910000  |d 910100  |e 910000PW1050230906  |e 910100PW1050230906  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 110903137  |a Mikus, Gerd  |m 110903137:Mikus, Gerd  |d 910000  |d 910100  |d 50000  |e 910000PM110903137  |e 910100PM110903137  |e 50000PM110903137  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 4 
998 |g 1034228889  |a Burhenne, Jürgen  |m 1034228889:Burhenne, Jürgen  |d 910000  |d 910100  |e 910000PB1034228889  |e 910100PB1034228889  |k 0/910000/  |k 1/910000/910100/  |p 3 
999 |a KXP-PPN1758140259  |e 3929574675 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1758140259","note":["Gesehen am 19.05.2021"],"language":["eng"],"person":[{"roleDisplay":"VerfasserIn","role":"aut","given":"Margit","display":"Fröhlich, Margit","family":"Fröhlich"},{"family":"Hoffmann","roleDisplay":"VerfasserIn","role":"aut","given":"Michael Marcus","display":"Hoffmann, Michael Marcus"},{"family":"Burhenne","roleDisplay":"VerfasserIn","role":"aut","given":"Jürgen","display":"Burhenne, Jürgen"},{"family":"Mikus","display":"Mikus, Gerd","role":"aut","roleDisplay":"VerfasserIn","given":"Gerd"},{"family":"Weiß","display":"Weiß, Johanna","role":"aut","roleDisplay":"VerfasserIn","given":"Johanna"},{"roleDisplay":"VerfasserIn","role":"aut","given":"Walter E.","display":"Haefeli, Walter E.","family":"Haefeli"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell","dateIssuedDisp":"1974-","publisherPlace":"Oxford ; Oxford ; Oxford [u.a.]","dateIssuedKey":"1974"}],"language":["eng"],"disp":"Association of the CYP3A5 A6986G (CYP3A5*3) polymorphism with saquinavir pharmacokineticsBritish journal of clinical pharmacology","title":[{"subtitle":"BJCP","title":"British journal of clinical pharmacology","title_sort":"British journal of clinical pharmacology"}],"id":{"eki":["306585995"],"zdb":["1498142-7"],"issn":["1365-2125"],"doi":["10.1111/(ISSN)1365-2125"]},"titleAlt":[{"title":"BJCP"}],"pubHistory":["1.1974 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 20.03.2014"],"part":{"issue":"4","volume":"58","pages":"443-444","extent":"2","year":"2004","text":"58(2004), 4, Seite 443-444"},"recId":"306585995"}],"name":{"displayForm":["Margit Fröhlich, Michael M Hoffmann, Jürgen Burhenne, Gerd Mikus, Johanna Weiss & Walter E Haefeli"]},"physDesc":[{"extent":"2 S."}],"id":{"eki":["1758140259"],"doi":["10.1111/j.1365-2125.2004.02159.x"]},"origin":[{"dateIssuedDisp":"21 June 2004","dateIssuedKey":"2004"}],"title":[{"title_sort":"Association of the CYP3A5 A6986G (CYP3A5*3) polymorphism with saquinavir pharmacokinetics","title":"Association of the CYP3A5 A6986G (CYP3A5*3) polymorphism with saquinavir pharmacokinetics"}]} 
SRT |a FROEHLICHMASSOCIATIO2120